Tuesday, October 21, 2014

Click below to purchase eBooks. 
Use Code NJ2014 for NJSHP.

Member Benefits
  • Continuing Education Opportunities
  • Professional Advocacy
  • Networking Opportunities  
  • Learn More...

ASHP Health-System Pharmacy News

Mon, 20 Oct 2014 00:00:00 -0400

FDA last week approved the marketing of nintedanib, or Ofev, for the treatment of idiopathic pulmonary fibrosis.

Fri, 17 Oct 2014 00:00:00 -0400

Before their hospital became the first to report what evolved into a nationwide outbreak of severe enterovirus D-68 (EV-D68) infections, the pharmacy staff at Children's Mercy Hospital and Clinics in Kansas City, Missouri, noticed some unexpected things happening with their drug inventory.

Thu, 16 Oct 2014 00:00:00 -0400

FDA on October 15 approved the marketing of pirfenidone, or Esbriet, for the treatment of idiopathic pulmonary fibrosis.

Tue, 14 Oct 2014 00:00:00 -0400

Gilead Sciences on October 10 announced the approval of Harvoni, a two-drug combination product for the treatment of chronic hepatitis C virus (HCV) genotype 1 infection in adults.

Tue, 14 Oct 2014 00:00:00 -0400

FDA on October 10 approved the marketing of sulfur hexafluoride lipid microspheres for use during echocardiography to improve images of the left ventricular chamber and endocardial border in patients whose previous echocardiograms of those areas have been suboptimal.

Home   |   Membership   |   Chapters   |   Councils   |   Events   |   Resources   |   Employment   |   About Us
Copyright 2012 by NJSHP